Chinese Clinical Oncology ›› 2018, Vol. 23 ›› Issue (5): 458-462.

Previous Articles     Next Articles

Progression of long chain non coding RNA in the regulation of drug resistance in colorectal cancer

  

  1. Department of Clinical Medicine， the First Clinical Medical College，Nanjing Medical University， Nanjing 210029， China
  • Received:2017-10-07 Revised:2018-01-20 Online:2018-05-31 Published:2018-06-07

PDF (PC)

330

Abstract: Colorectal cancer has the characteristics of high incidence and high mortality. Chemotherapy is one of the conventional treatment methods. The production of tumor resistance is the main reason for the failure of chemotherapy. Long chain non coding RNA （lncRNA） is involved in many physiological and pathological processes， and plays an important role in tumor proliferation， apoptosis， drug resistance and metastasis. Therefore， it is of practical significance to study the role of lncRNA in the drug resistance of colorectal cancer. In this review， we reviewed the progression of lncRNA in drug resistance mechanism of colorectal cancer at home and abroad.

Key words: Colorectal cancer, Long chain non coding RNA（lncRNA）, Chemoresistance

CLC Number: 

  • R735.3
[1] MENG Cunying, AN Tai, SHI Shengmei, ZHANG Chunli, LIU Yan, YUAN Donghong, MA Ying, LIU Pengfei.. Expression of DCLK1 and Bmi-1 in colorectal cancer and their clinical significance [J]. Chinese Clinical Oncology, 2018, 23(5): 419-423.
[2] ZHANG Dezhi, ZHANG Yu, ZHU Shaogong.. Effect of rs10013228 polymorphism of VEGFR2 gene on prognosis of patients with R0 resection of colorectal cancer [J]. Chinese Clinical Oncology, 2018, 23(5): 424-428.
[3] WANG Shanshan, WANG Haiyan, WU Bin, ZHAO Lihong, LI Dong, XIE Yan. . Observation of apatinib mesylate treatment on colon cancer failed in multi-line chemotherapy [J]. Chinese Clinical Oncology, 2018, 23(5): 453-457.
[4] YAO Bo, LU Na.. The role of radiotherapy in the management of rectal cancer with synchronous metastases [J]. Chinese Clinical Oncology, 2018, 23(5): 463-466.
[5] . Ｐｒｏｇｒｅｓｓｉｏｎ ｏｆ ｍｏｎｏｃｏｌｏｎａｌ ａｎｔｉｂｏｄｉｅｓ ｆｏｒ ｃｏｌｏｒｅｃｔａｌ ｃａｎｃｅｒ ｉｎ 2008 [J]. Chinese Clinical Oncology, 2009, 14(1): 1-.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Chinese Clinical Oncology, 2009, 14(1): 96 .
[2] . [J]. Chinese Clinical Oncology, 2009, 14(1): 89 .
[3] . [J]. Chinese Clinical Oncology, 2009, 14(1): 80 .
[4] . [J]. Chinese Clinical Oncology, 2009, 14(1): 74 .
[5] . [J]. Chinese Clinical Oncology, 2009, 14(1): 47 .
[6] . [J]. Chinese Clinical Oncology, 2009, 14(1): 68 .
[7] ＸＵＷｅｉ-ｇｕｏ，ＹＡＮＧＸｉａｏ-ｑｉｎｇ，ＨＡＯＳｈｉ-ｚｈｕ，ＳＯＮＧＪｉ-ｎｉｎｇ，ＺＨＡＮＧＰｅｎｇ-ｄｏｎｇ，ＨＵＣｈａｎ-ｃｈａｎ，ＷＡＮＧＷｅｎ-ｙａ. Ｔｈｅｅｘｐｒｅｓｓｉｏｎｏｆｎｅｕｒｏｐｉｌｉｎ-１ａｎｄｉｔｓｃｏｒｒｅｌａｔｉｏｎｗｉｔｈａｎｇｉｏｇｅｎｅｓｉｓｉｎｃｏｌｏｒｅｃｔａｌｃａｎｃｅ[J]. Chinese Clinical Oncology, 2009, 14(1): 29 .
[8] . [J]. Chinese Clinical Oncology, 2009, 14(1): 70 .
[9] . [J]. Chinese Clinical Oncology, 2009, 14(1): 43 .
[10] . [J]. Chinese Clinical Oncology, 2009, 14(1): 51 .
Copyright © Chinese Clinical Oncology, All Rights Reserved.
Tel: 025-84400143 85862116　E-mail: lczlx@csco.org.cn; lczlx@vip.163.com
Powered by Beijing Magtech Co. Ltd